{"nctId":"NCT02151253","briefTitle":"Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia","startDateStruct":{"date":"2011-05"},"conditions":["Nocturia","Daytime Sleepiness"],"count":81,"armGroups":[{"label":"Armodafinil First, Then Placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Armodafinil","Drug: Placebo"]},{"label":"Placebo First, Then Armodafinil","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Armodafinil","Drug: Placebo"]}],"interventions":[{"name":"Armodafinil","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Receiving standard-of-care therapy for nocturia based on assessment by study physician\n2. Evaluation by study physician indicates that the patient meets criteria for either overactive bladder diagnosis, or nocturnal polyuria diagnosis.\n3. Mean number of nocturia episodes at least 2 per night based on day sleep/bladder diary\n4. Epworth Sleepiness Scale Score of at least 10\n5. Clinical Global Impression of Sleepiness at least Moderate\n6. Age 18-90 years inclusive\n\nExclusion Criteria:\n\n1. Medications affecting urinary or sleep-wake function other than therapy for OAB o or NP within 5 half-lives of baseline assessment\n2. Sleep disorders other than nocturia based on history and screening assessment\n3. Unstable medical or psychiatry conditions\n4. Medical or psychiatric conditions affecting sleep/wake or urologic function\n5. Apnea-Hypopnea Index (AHI) ≥ 15 on screening polysomnogram\n6. Periodic Leg Movement Arousal Index (PLMAI) ≥ 15 on screening polysomnogram\n7. History of substance abuse or dependence in the last year\n8. Regular consumption of over 800 mg of caffeine use\n9. Shift-work in the 3 months prior to or during the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Epworth Sleepiness Scale [ESS]","description":"Epworth sleepiness scale (ESS) is measure of subjective sleepiness. Tendency to fall asleep in 8 situations. Total varies from zero to 24. A ESS of 10 or less is considered normal. Change is calculated as value at baseline minus value at week 4.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.03","spread":"5.18"},{"groupId":"OG001","value":"9.73","spread":"4.43"}]}]}]},{"type":"SECONDARY","title":"Clinical Global Impressions, Change in Severity of Excessive Daytime Sleepiness (EDS)","description":"Scale consists of a 7 point likert rating scale where the anchors were 1= \"normal\"; 2= \"borderline sleepiness\"; 3= \"mild sleepiness\"; 4= \"moderate sleepiness\"; 5= \"marked sleepiness\"; 6= \"severe sleepiness\"; and 7= \"among the most extremely sleepy individuals\"","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.58","spread":"1.03"},{"groupId":"OG001","value":"3.12","spread":"0.82"}]}]}]},{"type":"SECONDARY","title":"Mean Number of Naps/Day","description":"measurements are for the preceding week","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.48","spread":"0.71"},{"groupId":"OG001","value":"0.73","spread":"1.20"}]}]}]},{"type":"SECONDARY","title":"Mean Number of Minutes Napped Per Day Based on Sleep Diary","description":"measurements are for the preceding week","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.9","spread":"65.1"},{"groupId":"OG001","value":"40.0","spread":"61.3"}]}]}]},{"type":"SECONDARY","title":"Mean Number of Nocturic Events (Episode of Urination Preceded and Followed by Sleep)","description":"Nocturic Events is defined as an episode of urination preceded and followed by sleep. Measurements are for the preceding week","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":"1.1"},{"groupId":"OG001","value":"1.89","spread":"1.1"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":["Upper Respiratory Infection","Anxiety/Jitteriness","Nausea","Sinus Infection","insomnia"]}}}